White Cystalline Powder Pharma Raw Materials For Medicines Nateglinide 105816-04-4
Nateglinide lowers blood glucose by stimulating the release of insulin from the pancreas. It achieves this by closing ATP-dependent potassium channels in the membrane of the β cells. This depolarizes the β cells and causes voltage-gated calcium channels to open. The resulting calcium influx induces fusion of insulin-containing vesicles with the cell membrane, and insulin secretion occurs.
It can be used for diet control and /or exercise therapy for unsatisfactory control of blood glucose levels of
type 2 diabets mellitus inpatients. It can be used as second-line drugs in treating typee 2 diabets mellitus inpatients with unsatisfactory control of blood glucose lecels as